Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$1,081,800
+$146,811 QoQ
Shares Held
4,299
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.35%
of 13F equity value
Holder Rank
#2,467
of 4,153 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WASHINGTON GROWTH STRATEGIES LLC holds $1,904,465 across 3 Drug Manufacturers - General names. ABBV ranks #1 (56.8% of the industry book) .
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,081,800 | 4,299 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $934,989 | 4,299 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $982,278 | 4,299 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $995,390 | 4,299 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $797,980 | 4,299 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $621 | 210 | Shares | Sole | 2025-05-09 | |
| 2024-09-30 | $2,962 | 575 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||